DR. ALBERTO PARRA MD NPI 1376836718

NPI Information

  • NPI: 1376836718
  • Provider Name: DR. ALBERTO PARRA, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 515 W MAYFIELD RD STE 102
    ARLINGTON, TX
    ZIP 76014
  • Phone: (817) 759-7000

Map and Directions

Get Directions

NPI Details

DR. Alberto Parra, MD is a hematology and oncology internal medicine in Arlington, TX with 14 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Alberto Parra, MD NPI is 1376836718. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS MEDICAL SCHOOL AT SAN ANTONIO
Graduation Year:2011

The provider's business location address is:

515 W MAYFIELD RD STE 102
ARLINGTON, TX
ZIP 76014-084
Phone: (817) 759-7000
Fax: (817) 759-7027

The NPI 1376836718 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, triptorelin pamoate, 3.75 mg (HCPCS:J3315)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count (HCPCS:K1034)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Nuclear medicine study of bone and/or joint whole body (HCPCS:78306)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries (HCPCS:A9503)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Advance care planning, first 30 minutes (HCPCS:99497)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)

The enumeration date for this NPI number is 5/18/2011 and was last updated on 2/6/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal MedicineQ1256TEXASNo
2207RH0003XInternal MedicineHematology & OncologyQ1256TEXASYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.